RE:Pelareorep + Paclitaxel = Metastatic HR+/HER2– Breast CancerDe-escalation of axillary surgery performed to remove breast cancer that has already spread to nearby lymph nodes and prevent further metastasis could reduce the likelihood of a patient with breast cancer developing postoperative complications, including arm lymphedema, chronic pain, chronic fluid collections, problems with range of motion in the shoulder, and axillary web syndrome.
https://www.onclive.com/view/dr-coopey-on-the-benefits-of-axillary-surgery-omission-or-de-escalation-in-breast-cancer
[The benefits seen with the de-escalation of axillary lymph node surgery for patients with breast cancer could further be enhanced with the early introduction of immunotherapy treatment strategies, like that with ONCY's pelareorep in combination with paclitaxel, for example, in contrast to conventional surgical intervention.]